BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol. 2006;81:146-156. [PMID: 16643892 DOI: 10.1016/j.yexmp.2006.03.003] [Cited by in Crossref: 153] [Cited by in F6Publishing: 149] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Liu A, Liu D, Zhao S, Zheng J, Cao D, Zhang H. Up regulation of annexin A2 on murine H22 hepatocarcinoma cells induced by cartilage polysaccharide. Cancer Epidemiol. 2011;35:490-496. [PMID: 21111695 DOI: 10.1016/j.canep.2010.10.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
2 Wang T, Zhang KH. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma. Front Oncol 2020;10:1316. [PMID: 32923383 DOI: 10.3389/fonc.2020.01316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
3 Lu L, Qi H, Zhu J, Sun WX, Zhang B, Tang CY, Cheng Q. Vascular-homing peptides for cancer therapy. Biomed Pharmacother 2017;92:187-95. [PMID: 28544932 DOI: 10.1016/j.biopha.2017.05.054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
4 Zhao P, Zhang W, Tang J, Ma XK, Dai JY, Li Y, Jiang JL, Zhang SH, Chen ZN. Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci. 2010;101:387-395. [PMID: 20047591 DOI: 10.1111/j.1349-7006.2009.01420.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
5 Tristante E, Martínez CM, Jiménez S, Mora L, Carballo F, Martínez-Lacaci I, de Torre-Minguela C. Association of a characteristic membrane pattern of annexin A2 with high invasiveness and nodal status in colon adenocarcinoma. Transl Res 2015;166:196-206. [PMID: 25795236 DOI: 10.1016/j.trsl.2015.02.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
6 Li X, Zheng S, Liu Q, Liu T, Liang M, Gao X, Lu M, Sheyhidin I, Lu X. Under-expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma. Mol Carcinog 2015;54:779-88. [PMID: 24668792 DOI: 10.1002/mc.22145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Zhong LP, Wei KJ, Yang X, Zhang L, Zhou XJ, Pan HY, Li J, Chen WT, Zhang ZY. Increased expression of Annexin A2 in oral squamous cell carcinoma. Arch Oral Biol 2009;54:17-25. [PMID: 18822406 DOI: 10.1016/j.archoralbio.2008.08.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
8 Roy J, Wycislo KL, Pondenis H, Fan TM, Das A. Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin. PLoS One 2017;12:e0183930. [PMID: 28910304 DOI: 10.1371/journal.pone.0183930] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
9 Shen D, Xu B, Liang K, Tang R, Sudlow GP, Egbulefu C, Guo K, Som A, Gilson R, Maji D, Mondal S, Habimana-Griffin L, Akers WJ, Li S, Liu Y, Bloch S, Kurkure S, Nussinov Z, Seidel A, Tsen SD, Achilefu S. Selective imaging of solid tumours via the calcium-dependent high-affinity binding of a cyclic octapeptide to phosphorylated Annexin A2. Nat Biomed Eng 2020;4:298-313. [PMID: 32165732 DOI: 10.1038/s41551-020-0528-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
10 Ka SM, Tsai PY, Chao TK, Yang SM, Hung YJ, Chen JS, Shui HA, Chen A. Urine annexin A1 as an index for glomerular injury in patients. Dis Markers 2014;2014:854163. [PMID: 24591769 DOI: 10.1155/2014/854163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
11 Han F, Shrestha S, Huang H, Lv HY, Nie C, Lin L, Lu ML. Expression of annexin II in gastric carcinoma and its role in gastric cancer metastasis. World J Gastroenterol 2017; 23(38): 7009-7015 [PMID: 29097873 DOI: 10.3748/wjg.v23.i38.7009] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
12 Wang CY, Chen CL, Tseng YL, Fang YT, Lin YS, Su WC, Chen CC, Chang KC, Wang YC, Lin CF. Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. J Biol Chem 2012;287:32512-24. [PMID: 22859294 DOI: 10.1074/jbc.M112.351957] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
13 Sharma M, Ownbey RT, Sharma MC. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol. 2010;88:278-286. [PMID: 20079732 DOI: 10.1016/j.yexmp.2010.01.001] [Cited by in Crossref: 83] [Cited by in F6Publishing: 87] [Article Influence: 7.5] [Reference Citation Analysis]
14 Sharma MC, Tuszynski GP, Blackman MR, Sharma M. Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer. Cancer Lett 2016;373:27-35. [PMID: 26797420 DOI: 10.1016/j.canlet.2016.01.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
15 Zhang F, Liu Y, Wang Z, Sun X, Yuan J, Wang T, Tian R, Ji W, Yu M, Zhao Y, Niu R. A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level. Mol Cell Endocrinol 2015;411:75-85. [PMID: 25917452 DOI: 10.1016/j.mce.2015.04.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
16 Jia JW, Li KL, Wu JX, Guo SL. Clinical significance of annexin II expression in human non-small cell lung cancer. Tumour Biol. 2013;34:1767-1771. [PMID: 23494179 DOI: 10.1007/s13277-013-0715-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
17 Protzel C, Richter M, Poetsch M, Kakies C, Zimmermann U, Woenckhaus C, Klebingat KJ, Hakenberg OW, Giebel J. The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas. World J Urol. 2011;29:393-398. [PMID: 20602103 DOI: 10.1007/s00345-010-0575-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
18 Chuthapisith S, Bean BE, Cowley G, Eremin JM, Samphao S, Layfield R, Kerr ID, Wiseman J, El-Sheemy M, Sreenivasan T, Eremin O. Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer 2009;45:1274-81. [PMID: 19171478 DOI: 10.1016/j.ejca.2008.12.026] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
19 Solbak SMØ, Abdurakhmanov E, Vedeler A, Danielson UH. Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA - effects on NS5B catalysis and allosteric inhibition. Virol J 2017;14:236. [PMID: 29228983 DOI: 10.1186/s12985-017-0904-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
20 Zhang Y, Bi J, Zhu H, Shi M, Zeng X. ANXA2 could act as a moderator of EGFR-directed therapy resistance in triple negative breast cancer. Bioscience, Biotechnology, and Biochemistry 2018;82:1733-41. [DOI: 10.1080/09168451.2018.1484275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
21 Corrado C, Saieva L, Raimondo S, Santoro A, De Leo G, Alessandro R. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. J Cell Mol Med 2016;20:1829-39. [PMID: 27196940 DOI: 10.1111/jcmm.12873] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis]
22 Shang X, Sun J, He Y, Zhao W, Li Q, Zhou F, Chen B, Cheng H, Zhou R. Identification and predominant expression of annexin A2 in epithelial-type cells of the rice field eel. J Cell Biochem 2007;101:600-8. [PMID: 17226778 DOI: 10.1002/jcb.21219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
23 Das S, Shetty P, Valapala M, Dasgupta S, Gryczynski Z, Vishwanatha JK. Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells. Biochemistry 2010;49:2216-26. [PMID: 20121258 DOI: 10.1021/bi9013038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
24 Betancourt AM, Wang J, Jenkins S, Mobley J, Russo J, Lamartiniere CA. Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genistein. J Nutr 2012;142:1382S-8S. [PMID: 22649256 DOI: 10.3945/jn.111.152058] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
25 Hussain S, Saxena S, Shrivastava S, Mohanty AK, Kumar S, Singh RJ, Kumar A, Wani SA, Gandham RK, Kumar N, Sharma AK, Tiwari AK, Singh RK. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis. PLoS One 2018;13:e0208656. [PMID: 30517191 DOI: 10.1371/journal.pone.0208656] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
26 Paudel N, Sadagopan S, Balasubramanian S, Chandran B. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells. J Virol 2012;86:1589-607. [PMID: 22130534 DOI: 10.1128/JVI.05754-11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
27 Liu W, Hajjar KA. The annexin A2 system and angiogenesis. Biol Chem 2016;397:1005-16. [PMID: 27366903 DOI: 10.1515/hsz-2016-0166] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
28 Lei Y, Wang K, Li X, Li Y, Feng X, Zhou J, Zhang Z, Huang C, Zhang T. Cell-surface translocation of annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice. Clin Sci (Lond). 2019;133:789-804. [PMID: 30902828 DOI: 10.1042/cs20180687] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
29 Jung Y, Wang J, Lee E, McGee S, Berry JE, Yumoto K, Dai J, Keller ET, Shiozawa Y, Taichman RS. Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow. Mol Cancer Res 2015;13:197-207. [PMID: 25139998 DOI: 10.1158/1541-7786.MCR-14-0118] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
30 Chen CY, Lin YS, Chen CL, Chao PZ, Chiou JF, Kuo CC, Lee FP, Lin YF, Sung YH, Lin YT, Li CF, Chen YJ, Chen CH. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma. Oncotarget 2015;6:26946-59. [PMID: 26196246 DOI: 10.18632/oncotarget.4521] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
31 Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, Shroyer KR, Hajjar KA, Tsirka SE. Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci. 2011;31:14346-14360. [PMID: 21976520 DOI: 10.1523/jneurosci.3299-11.2011] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
32 Dias C, Nylandsted J. Plasma membrane integrity in health and disease: significance and therapeutic potential. Cell Discov 2021;7:4. [PMID: 33462191 DOI: 10.1038/s41421-020-00233-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
33 Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2015; 21(37): 10573-10583 [PMID: 26457017 DOI: 10.3748/wjg.v21.i37.10573] [Cited by in CrossRef: 188] [Cited by in F6Publishing: 181] [Article Influence: 31.3] [Reference Citation Analysis]
34 Tauro BJ, Mathias RA, Greening DW, Gopal SK, Ji H, Kapp EA, Coleman BM, Hill AF, Kusebauch U, Hallows JL. Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition. Mol Cell Proteomics. 2013;12:2148-2159. [PMID: 23645497 DOI: 10.1074/mcp.m112.027086] [Cited by in Crossref: 125] [Cited by in F6Publishing: 73] [Article Influence: 15.6] [Reference Citation Analysis]
35 Moreau K, Ghislat G, Hochfeld W, Renna M, Zavodszky E, Runwal G, Puri C, Lee S, Siddiqi F, Menzies FM, Ravikumar B, Rubinsztein DC. Transcriptional regulation of Annexin A2 promotes starvation-induced autophagy. Nat Commun 2015;6:8045. [PMID: 26289944 DOI: 10.1038/ncomms9045] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
36 Imai K, Ichibangase T, Saitoh R, Hoshikawa Y. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry. Biomed Chromatogr 2008;22:1304-14. [DOI: 10.1002/bmc.1102] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
37 Sharma MC. Annexin A2: An emerging biomarker and potential therapeutic target for aggressive cancers. Int J Cancer. 2019;144:2074-2081. [PMID: 30125343 DOI: 10.1002/ijc.31817] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
38 Reichl P, Mikulits W. Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review). Oncol Rep. 2016;36:613-625. [PMID: 27278244 DOI: 10.3892/or.2016.4842] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
39 Zhang Q, Zhao Z, Ma Y, Wang H, Ma J, He X, Zhang D. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma. Urol Oncol 2014;32:798-805. [PMID: 24968947 DOI: 10.1016/j.urolonc.2014.02.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
40 Koumangoye RB, Sakwe AM, Goodwin JS, Patel T, Ochieng J. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS One 2011;6:e24234. [PMID: 21915303 DOI: 10.1371/journal.pone.0024234] [Cited by in Crossref: 135] [Cited by in F6Publishing: 125] [Article Influence: 13.5] [Reference Citation Analysis]
41 Sharma M, Blackman MR, Sharma MC. Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model. Exp Mol Pathol 2012;92:175-84. [PMID: 22044461 DOI: 10.1016/j.yexmp.2011.10.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
42 Lo JH, Chen TT. Production of bioactive recombinant human Eb-peptide of pro-IGF-I and identification of binding components from the plasma membrane of human breast cancer cells (MDA-MB-231). Exp Cell Res 2018;362:235-43. [PMID: 29191552 DOI: 10.1016/j.yexcr.2017.11.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Luo M, Hajjar KA. Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost. 2013;39:338-346. [PMID: 23483454 DOI: 10.1055/s-0033-1334143] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
44 Barua A, Edassery SL, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric MJ, Luborsky JL. Prevalence of antitumor antibodies in laying hen model of human ovarian cancer. Int J Gynecol Cancer 2009;19:500-7. [PMID: 19509543 DOI: 10.1111/IGC.0b013e3181a39db1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
45 Singh P. Role of Annexin-II in GI cancers: interaction with gastrins/progastrins. Cancer Lett 2007;252:19-35. [PMID: 17188424 DOI: 10.1016/j.canlet.2006.11.012] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
46 Seth D, Hogg PJ, Gorrell MD, McCaughan GW, Haber PS. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. J Hepatol. 2008;48:614-627. [PMID: 18289715 DOI: 10.1016/j.jhep.2007.12.015] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
47 Aareskjold E, Grindheim AK, Hollås H, Goris M, Lillehaug JR, Vedeler A. Two tales of Annexin A2 knock-down: One of compensatory effects by antisense RNA and another of a highly active hairpin ribozyme. Biochem Pharmacol 2019;166:253-63. [PMID: 31158338 DOI: 10.1016/j.bcp.2019.05.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Avula LR, Hagerty B, Alewine C. Molecular mediators of peritoneal metastasis in pancreatic cancer. Cancer Metastasis Rev 2020;39:1223-43. [PMID: 32780245 DOI: 10.1007/s10555-020-09924-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
49 Didiasova M, Wujak L, Wygrecka M, Zakrzewicz D. From plasminogen to plasmin: role of plasminogen receptors in human cancer. Int J Mol Sci 2014;15:21229-52. [PMID: 25407528 DOI: 10.3390/ijms151121229] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
50 Chaudhary P, Gibbs LD, Maji S, Lewis CM, Suzuki S, Vishwanatha JK. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis. Breast Cancer Res 2020;22:11. [PMID: 31992335 DOI: 10.1186/s13058-020-1251-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
51 Lu S, Chen Y, Shun C, Lai J, Peng S, Lai P, Hsu H. Expression and prognostic significance of gastric-specific annexin A10 in diffuse- and intestinal-type gastric carcinoma: Annexin A10 expression in gastric carcinoma. Journal of Gastroenterology and Hepatology 2011;26:90-7. [DOI: 10.1111/j.1440-1746.2010.06480.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
52 Haskins WE, Zablotsky BL, Foret MR, Ihrie RA, Alvarez-Buylla A, Eisenman RN, Berger MS, Lin CH. Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme. Front Oncol 2013;3:182. [PMID: 23875172 DOI: 10.3389/fonc.2013.00182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
53 Maruo T, Ichikawa T, Kanzaki H, Inoue S, Kurozumi K, Onishi M, Yoshida K, Kambara H, Ouchida M, Shimizu K, Tamaru S, Chiocca EA, Date I. Proteomics-based analysis of invasion-related proteins in malignant gliomas. Neuropathology 2013;33:264-75. [PMID: 23116197 DOI: 10.1111/j.1440-1789.2012.01361.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
54 Zheng Y, Lin Y, Situ D, Jiang L, Su X, Long H. Analysis of differently expressed proteins involved in metastatic niche of lung. Thorac Cancer 2013;4:385-94. [PMID: 28920209 DOI: 10.1111/1759-7714.12033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
55 Reddy TR, Li C, Guo X, Myrvang HK, Fischer PM, Dekker LV. Design, synthesis, and structure-activity relationship exploration of 1-substituted 4-aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one analogues as inhibitors of the annexin A2-S100A10 protein interaction. J Med Chem. 2011;54:2080-2094. [PMID: 21375334 DOI: 10.1021/jm101212e] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
56 McCready J, Sims JD, Chan D, Jay DG. Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer. 2010;10:294. [PMID: 20553606 DOI: 10.1186/1471-2407-10-294] [Cited by in Crossref: 182] [Cited by in F6Publishing: 172] [Article Influence: 16.5] [Reference Citation Analysis]
57 Raimondo F, Salemi C, Chinello C, Fumagalli D, Morosi L, Rocco F, Ferrero S, Perego R, Bianchi C, Sarto C, Pitto M, Brambilla P, Magni F. Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE. Mol Biosyst 2012;8:1040-51. [PMID: 22315040 DOI: 10.1039/c2mb05390j] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
58 Regimbeau M, Abrey J, Vautrot V, Causse S, Gobbo J, Garrido C. Heat shock proteins and exosomes in cancer theranostics. Semin Cancer Biol 2021:S1044-579X(21)00209-1. [PMID: 34343652 DOI: 10.1016/j.semcancer.2021.07.014] [Reference Citation Analysis]
59 Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Hsi E, Suen JL, Hung CH, Lee JN, Chai CY, Wang SC, Tsai EM. n-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1. PLoS One 2012;7:e42750. [PMID: 22905168 DOI: 10.1371/journal.pone.0042750] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
60 Zhang F, Wang Z, Yuan J, Wei X, Tian R, Niu R. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway. Breast Cancer Res Treat. 2015;153:263-275. [PMID: 26253946 DOI: 10.1007/s10549-015-3529-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
61 Al-Qahtani SM, Gadalla SE, Guo M, Ericsson C, Hägerstrand D, Nistér M. The association between Annexin A2 and epithelial cell adhesion molecule in breast cancer cells. Cancer Rep (Hoboken) 2021;:e1498. [PMID: 34240826 DOI: 10.1002/cnr2.1498] [Reference Citation Analysis]
62 Cui L, Song J, Wu L, Cheng L, Chen A, Wang Y, Huang Y, Huang L. Role of Annexin A2 in the EGF-induced epithelial-mesenchymal transition in human CaSki cells. Oncol Lett 2017;13:377-83. [PMID: 28123570 DOI: 10.3892/ol.2016.5406] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
63 Wang YQ, Zhang F, Tian R, Ji W, Zhou Y, Sun XM, Liu Y, Wang ZY, Niu RF. Tyrosine 23 Phosphorylation of Annexin A2 Promotes Proliferation, Invasion, and Stat3 Phosphorylation in the Nucleus of Human Breast Cancer SK-BR-3 Cells. Cancer Biol Med 2012;9:248-53. [PMID: 23691485 DOI: 10.7497/j.issn.2095-3941.2012.04.005] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
64 Jeon YR, Kim SY, Lee EJ, Kim YN, Noh DY, Park SY, Moon A. Identification of annexin II as a novel secretory biomarker for breast cancer. Proteomics. 2013;13:3145-3156. [PMID: 24019232 DOI: 10.1002/pmic.201300127] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
65 Mussunoor S, Murray GI. The role of annexins in tumour development and progression. J Pathol. 2008;216:131-140. [PMID: 18698663 DOI: 10.1002/path.2400] [Cited by in Crossref: 176] [Cited by in F6Publishing: 178] [Article Influence: 13.5] [Reference Citation Analysis]
66 Qin YY, Huang SN, Chen G, Pang YY, Li XJ, Xing WW, Wei DM, He Y, Rong MH, Tang XZ. Clinicopathological value and underlying molecular mechanism of annexin A2 in 992 cases of thyroid carcinoma. Comput Biol Chem 2020;86:107258. [PMID: 32304977 DOI: 10.1016/j.compbiolchem.2020.107258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
67 Cao HH, Zhang SY, Shen JH, Wu ZY, Wu JY, Wang SH, Li EM, Xu LY. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma. Oncotarget. 2015;6:5435-5448. [PMID: 25605255 DOI: 10.18632/oncotarget.3102] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
68 Zhang Q, Ye Z, Yang Q, He X, Wang H, Zhao Z. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. World J Surg Oncol. 2012;10:103. [PMID: 22681645 DOI: 10.1186/1477-7819-10-103] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
69 Schulz DM, Böllner C, Thomas G, Atkinson M, Esposito I, Höfler H, Aubele M. Identification of Differentially Expressed Proteins in Triple-Negative Breast Carcinomas Using DIGE and Mass Spectrometry. J Proteome Res 2009;8:3430-8. [DOI: 10.1021/pr900071h] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
70 Dallacasagrande V, Hajjar KA. Annexin A2 in Inflammation and Host Defense. Cells 2020;9:E1499. [PMID: 32575495 DOI: 10.3390/cells9061499] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
71 Li D, He C, Liu F, Li J, Gao J, Li Y, Xu W. Annexin A2, up-regulated by IL-6, promotes the ossification of ligament fibroblasts from ankylosing spondylitis patients. Biomedicine & Pharmacotherapy 2016;84:674-9. [DOI: 10.1016/j.biopha.2016.09.091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
72 Seckinger A, Meissner T, Moreaux J, Depeweg D, Hillengass J, Hose K, Rème T, Rösen-Wolff A, Jauch A, Schnettler R, Ewerbeck V, Goldschmidt H, Klein B, Hose D. Clinical and prognostic role of annexin A2 in multiple myeloma. Blood 2012;120:1087-94. [PMID: 22705595 DOI: 10.1182/blood-2012-03-415588] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
73 Tsunezumi J, Yamamoto K, Higashi S, Miyazaki K. Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces. FEBS J 2008;275:4810-23. [PMID: 18721140 DOI: 10.1111/j.1742-4658.2008.06620.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
74 Chen CY, Lin YS, Chen CH, Chen YJ. Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma. J Biomed Sci. 2018;25:30. [PMID: 29598816 DOI: 10.1186/s12929-018-0430-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
75 Dunne JC, Lamb DS, Delahunt B, Murray J, Bethwaite P, Ferguson P, Nacey JN, Sondhauss S, Jordan TW. Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease. Clin Proteomics 2015;12:24. [PMID: 26388710 DOI: 10.1186/s12014-015-9096-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
76 Deng Y, Chen C, Hua M, Xi Q, Liu R, Yang S, Liu J, Zhong J, Tang M, Lu S, Tang C, Wang Y. Annexin A2 plays a critical role in epithelial ovarian cancer. Arch Gynecol Obstet 2015;292:175-82. [PMID: 25547062 DOI: 10.1007/s00404-014-3598-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
77 Fan Y, Si W, Ji W, Wang Z, Gao Z, Tian R, Song W, Zhang H, Niu R, Zhang F. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells. Breast Cancer Res. 2019;21:66. [PMID: 31113450 DOI: 10.1186/s13058-019-1147-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
78 Sharma T, Radosevich JA, Pachori G, Mandal CC. A Molecular View of Pathological Microcalcification in Breast Cancer. J Mammary Gland Biol Neoplasia 2016;21:25-40. [DOI: 10.1007/s10911-015-9349-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
79 Lokman NA, Ween MP, Oehler MK, Ricciardelli C. The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron. 2011;4:199-208. [PMID: 21909879 DOI: 10.1007/s12307-011-0064-9] [Cited by in Crossref: 147] [Cited by in F6Publishing: 141] [Article Influence: 14.7] [Reference Citation Analysis]
80 Xing X, Yuan H, Sun Y, Ke K, Dong X, Chen H, Liu X, Zhao B, Huang A. ANXA2Tyr23 and FLNASer2152 phosphorylation associate with poor prognosis in hepatic carcinoma revealed by quantitative phosphoproteomics analysis. J Proteomics. 2019;200:111-122. [PMID: 30951906 DOI: 10.1016/j.jprot.2019.03.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
81 Grindheim AK, Saraste J, Vedeler A. Protein phosphorylation and its role in the regulation of Annexin A2 function. Biochim Biophys Acta Gen Subj 2017;1861:2515-29. [PMID: 28867585 DOI: 10.1016/j.bbagen.2017.08.024] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 10.8] [Reference Citation Analysis]
82 Shetty PK, Thamake SI, Biswas S, Johansson SL, Vishwanatha JK. Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer. PLoS One 2012;7:e44299. [PMID: 22957061 DOI: 10.1371/journal.pone.0044299] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
83 El-Abd N, Fawzy A, Elbaz T, Hamdy S. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma. Tumour Biol. 2016;37:211-216. [PMID: 26189841 DOI: 10.1007/s13277-015-3524-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
84 Gibbs LD, Chaudhary P, Mansheim K, Hare RJ, Mantsch RA, Vishwanatha JK. ANXA2 expression in African American triple-negative breast cancer patients. Breast Cancer Res Treat. 2019;174:113-120. [PMID: 30478786 DOI: 10.1007/s10549-018-5030-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
85 Yamanaka H, Kobayashi K, Okubo M, Noguchi K. Annexin A2 in primary afferents contributes to neuropathic pain associated with tissue type plasminogen activator. Neuroscience 2016;314:189-99. [DOI: 10.1016/j.neuroscience.2015.11.058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
86 Mahdi AF, Malacrida B, Nolan J, McCumiskey ME, Merrigan AB, Lal A, Tormey S, Lowery AJ, McGourty K, Kiely PA. Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers. Cells 2020;9:E1582. [PMID: 32629869 DOI: 10.3390/cells9071582] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
87 Duncan R, Carpenter B, Main LC, Telfer C, Murray GI. Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer. 2008;98:426-433. [PMID: 18071363 DOI: 10.1038/sj.bjc.6604128] [Cited by in Crossref: 151] [Cited by in F6Publishing: 150] [Article Influence: 10.8] [Reference Citation Analysis]
88 Onishi M, Ichikawa T, Kurozumi K, Inoue S, Maruo T, Otani Y, Fujii K, Ishida J, Shimazu Y, Yoshida K, Michiue H, Antonio Chiocca E, Date I. Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma. Brain Tumor Pathol 2015;32:184-94. [PMID: 25697644 DOI: 10.1007/s10014-015-0216-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
89 Rodrigo JP, Lequerica-Fernández P, Rosado P, Allonca E, García-Pedrero JM, de Vicente JC. Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma. Head Neck 2011;33:1708-14. [PMID: 21500302 DOI: 10.1002/hed.21661] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
90 Ceruti P, Principe M, Capello M, Cappello P, Novelli F. Three are better than one: plasminogen receptors as cancer theranostic targets. Exp Hematol Oncol 2013;2:12. [PMID: 23594883 DOI: 10.1186/2162-3619-2-12] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
91 Sun Y, Gao G, Cai J, Wang Y, Qu X, He L, Liu F, Zhang Y, Lin K, Ma S, Yang X, Qian X, Zhao X. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma. Carcinogenesis. 2013;34:595-604. [PMID: 23188673 DOI: 10.1093/carcin/bgs372] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
92 Kawasaki BT, Mistree T, Hurt EM, Kalathur M, Farrar WL. Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells. Biochem Biophys Res Commun 2007;364:778-82. [PMID: 17964286 DOI: 10.1016/j.bbrc.2007.10.067] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 4.6] [Reference Citation Analysis]
93 Yi W, Sun Y, Wei X, Gu C, Dong X, Kang X, Guo S, Dou K. Proteomic profiling of human bone marrow mesenchymal stem cells under shear stress. Mol Cell Biochem 2010;341:9-16. [PMID: 20407807 DOI: 10.1007/s11010-010-0432-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
94 Gibbs LD, Vishwanatha JK. Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer. Oncotarget 2018;9:2697-704. [DOI: 10.18632/oncotarget.23627] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
95 张志强, 聂永梅, 李秀娟, 夏宇, 胡翠梨, 苏丽萍, 李建洲, 宋娜, 蒋海, 张洁. ANXA2和ANXA4在胃腺癌中的表达及临床意义. 世界华人消化杂志 2012; 20(11): 930-935 [DOI: 10.11569/wcjd.v20.i11.930] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Mittal P, Klingler-Hoffmann M, Arentz G, Winderbaum L, Kaur G, Anderson L, Scurry J, Leung Y, Stewart CJ, Carter J, Hoffmann P, Oehler MK. Annexin A2 and alpha actinin 4 expression correlates with metastatic potential of primary endometrial cancer. Biochim Biophys Acta Proteins Proteom 2017;1865:846-57. [PMID: 27784647 DOI: 10.1016/j.bbapap.2016.10.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
97 Wang CY, Lin YS, Su WC, Chen CL, Lin CF. Glycogen synthase kinase-3 and Omi/HtrA2 induce annexin A2 cleavage followed by cell cycle inhibition and apoptosis. Mol Biol Cell 2009;20:4153-61. [PMID: 19656851 DOI: 10.1091/mbc.e09-02-0174] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
98 Song A, Liao G, Wu M, Lu Y, Ma D. Screening of differently expressed genes in human prostate cancer cell lines with different metastasis potentials. J Huazhong Univ Sci Technol [Med Sci ] 2007;27:582-5. [DOI: 10.1007/s11596-007-0527-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
99 Jiang M, Ren L, Chen Y, Wang H, Wu H, Cheng S, Li G, Yu S. Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer. Front Mol Biosci 2021;8:613359. [PMID: 34026819 DOI: 10.3389/fmolb.2021.613359] [Reference Citation Analysis]
100 Yun HJ, Cho YH, Moon Y, Park YW, Yoon HK, Kim YJ, Cho SH, Lee YI, Kang BS, Kim WJ, Park K, Seo W. Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2. Exp Mol Med 2008;40:345-53. [PMID: 18587273 DOI: 10.3858/emm.2008.40.3.345] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
101 Hastie C, Masters JR, Moss SE, Naaby-Hansen S. Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells. J Biol Chem 2008;283:12595-603. [PMID: 18211896 DOI: 10.1074/jbc.M800189200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
102 Graham N, Qian BZ. Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis. Int J Mol Sci 2018;19:E1121. [PMID: 29642534 DOI: 10.3390/ijms19041121] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
103 Leong L, Tan HL, Cua S, Yong KSM, Chen Q, Choo A. Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer. Int J Mol Sci 2020;21:E381. [PMID: 31936170 DOI: 10.3390/ijms21020381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
104 Mannello F, Qin W, Zhu W, Fabbri L, Tonti GA, Sauter ER. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2. Breast Cancer Res Treat 2008;111:209-18. [DOI: 10.1007/s10549-007-9779-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
105 Yuan J, Yang Y, Gao Z, Wang Z, Ji W, Song W, Zhang F, Niu R. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells. Breast Cancer Res Treat 2017;164:327-40. [PMID: 28470457 DOI: 10.1007/s10549-017-4271-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
106 Myrvang HK, Guo X, Li C, Dekker LV. Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells. FEBS Lett 2013;587:3210-5. [PMID: 23994525 DOI: 10.1016/j.febslet.2013.08.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
107 Hedhli N, Falcone DJ, Huang B, Cesarman-Maus G, Kraemer R, Zhai H, Tsirka SE, Santambrogio L, Hajjar KA. The annexin A2/S100A10 system in health and disease: emerging paradigms. J Biomed Biotechnol 2012;2012:406273. [PMID: 23193360 DOI: 10.1155/2012/406273] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
108 Meng Q, Lei T, Zhang M, Zhao J, Zhao XH, Zhang M. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis. J Cancer Res Clin Oncol 2013;139:509-19. [PMID: 23183654 DOI: 10.1007/s00432-012-1350-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
109 Li Z, Yu L, Hu B, Chen L, Jv M, Wang L, Zhou C, Wei M, Zhao L. Advances in cancer treatment: a new therapeutic target, Annexin A2. J Cancer 2021;12:3587-96. [PMID: 33995636 DOI: 10.7150/jca.55173] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Strand E, Hollås H, Sakya SA, Romanyuk S, Saraste MEV, Grindheim AK, Patil SS, Vedeler A. Annexin A2 binds the internal ribosomal entry site of c-myc mRNA and regulates its translation. RNA Biol 2021;:1-18. [PMID: 34346292 DOI: 10.1080/15476286.2021.1947648] [Reference Citation Analysis]
111 Wei M, Zhou Y, Li C, Yang Y, Liu T, Liu Y, Wei Y, Liu N, Liu S, Wang Q, Cao S, Sun Y, Sheng P, Lu C, Yang C, Liu X, Yang G. 5α-Epoxyalantolactone Inhibits Metastasis of Triple-Negative Breast Cancer Cells by Covalently Binding a Conserved Cysteine of Annexin A2. J Med Chem 2021. [PMID: 34351142 DOI: 10.1021/acs.jmedchem.1c00267] [Reference Citation Analysis]
112 Xie R, Liu J, Yu X, Li C, Wang Y, Yang W, Hu J, Liu P, Sui H, Liang P, Huang X, Wang L, Bai Y, Xue Y, Zhu J, Fang T. ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells. J Oncol. 2019;2019. [PMID: 31186633 DOI: 10.1155/2019/4035460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
113 Yang M, Wang C, Li S, Xv X, She S, Ran X, Li S, Hu H, Hu P, Zhang D, Zheng Y, Yang Y, Ren H. Annexin A2 promotes liver fibrosis by mediating von Willebrand factor secretion. Dig Liver Dis 2017;49:780-8. [PMID: 28377286 DOI: 10.1016/j.dld.2017.02.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
114 Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K, Tachibana M. Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer. 2009;101:287-294. [PMID: 19513064 DOI: 10.1038/sj.bjc.6605128] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
115 Viedma-Rodríguez R, Martínez-Hernández MG, Flores-López LA, Baiza-Gutman LA. Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system. Mol Cell Biochem 2018;437:65-80. [PMID: 28612231 DOI: 10.1007/s11010-017-3096-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
116 Lokman NA, Elder AS, Ween MP, Pyragius CE, Hoffmann P, Oehler MK, Ricciardelli C. Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget 2013;4:1199-211. [PMID: 23945256 DOI: 10.18632/oncotarget.1122] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
117 Zhang F, Zhang H, Wang Z, Yu M, Tian R, Ji W, Yang Y, Niu R. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells. Biochem Pharmacol 2014;87:292-302. [PMID: 24239898 DOI: 10.1016/j.bcp.2013.11.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
118 McGowan EM, Lin Y, Hatoum D. Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence. Cancers (Basel) 2018;10:E172. [PMID: 29857525 DOI: 10.3390/cancers10060172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
119 Zhang X, Liu S, Guo C, Zong J, Sun MZ. The association of annexin A2 and cancers. Clin Transl Oncol. 2012;14:634-640. [PMID: 22855149 DOI: 10.1007/s12094-012-0855-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
120 Hou Y, Yang L, Mou M, Hou Y, Zhang A, Pan N, Qiang R, Wei L, Zhang N. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Cancer Invest. 2008;26:809-815. [PMID: 18608216 DOI: 10.1080/07357900801898664] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
121 Wang T, Wang Z, Niu R, Wang L. Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism. Cancer Biol Med 2019;16:671-87. [PMID: 31908887 DOI: 10.20892/j.issn.2095-3941.2019.0228] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
122 Chaudhary P, Thamake SI, Shetty P, Vishwanatha JK. Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies. Br J Cancer 2014;111:2328-41. [PMID: 25321192 DOI: 10.1038/bjc.2014.542] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
123 Maule F, Bresolin S, Rampazzo E, Boso D, Della Puppa A, Esposito G, Porcù E, Mitola S, Lombardi G, Accordi B, Tumino M, Basso G, Persano L. Annexin 2A sustains glioblastoma cell dissemination and proliferation. Oncotarget 2016;7:54632-49. [PMID: 27429043 DOI: 10.18632/oncotarget.10565] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
124 Sharma MC, Jain D. Important role of annexin A2 (ANXA2) in new blood vessel development in vivo and human triple negative breast cancer (TNBC) growth. Exp Mol Pathol 2020;116:104523. [PMID: 32866522 DOI: 10.1016/j.yexmp.2020.104523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
125 Gibbs LD, Mansheim K, Maji S, Nandy R, Lewis CM, Vishwanatha JK, Chaudhary P. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients. Cancers (Basel) 2020;13:E2. [PMID: 33374917 DOI: 10.3390/cancers13010002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
126 Choi CH, Chung JY, Chung EJ, Sears JD, Lee JW, Bae DS, Hewitt SM. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer. BMC Cancer 2016;16:448. [PMID: 27402115 DOI: 10.1186/s12885-016-2459-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
127 Martín‐belmonte F, Rodríguez‐fraticelli AE. Chapter 3 Acquisition of Membrane Polarity in Epithelial Tube Formation. Elsevier; 2009. pp. 129-82. [DOI: 10.1016/s1937-6448(08)02003-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
128 Zhang W, Zhao P, Xu XL, Cai L, Song ZS, Cao DY, Tao KS, Zhou WP, Chen ZN, Dou KF. Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells. PLoS One 2013;8:e67268. [PMID: 23950866 DOI: 10.1371/journal.pone.0067268] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
129 Kazami T, Nie H, Satoh M, Kuga T, Matsushita K, Kawasaki N, Tomonaga T, Nomura F. Nuclear accumulation of annexin A2 contributes to chromosomal instability by coilin-mediated centromere damage. Oncogene 2015;34:4177-89. [PMID: 25347736 DOI: 10.1038/onc.2014.345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
130 Feng H, Li X, Niu D, Chen WN. Protein profile in HBx transfected cells: a comparative iTRAQ-coupled 2D LC-MS/MS analysis. J Proteomics 2010;73:1421-32. [PMID: 20026004 DOI: 10.1016/j.jprot.2009.12.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
131 Wang CY, Lin CF. Annexin A2: its molecular regulation and cellular expression in cancer development. Dis Markers. 2014;2014:308976. [PMID: 24591759 DOI: 10.1155/2014/308976] [Cited by in Crossref: 42] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
132 Li H, Wang Y, Lu Y, Li F. Annexin A2 interacting with ELMO1 regulates HCC chemotaxis and metastasis. Life Sci. 2019;222:168-174. [PMID: 30853625 DOI: 10.1016/j.lfs.2019.03.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
133 Zhong L, Zhang L, Yang X, Pan H, Zhou X, Wei K, Ye D, Jiang Q, Chen W, Zhang Z. Comparative proteomic analysis of differentially expressed proteins in an in vitro cellular carcinogenesis model of oral squamous cell carcinoma. Prot Clin Appl 2009;3:322-37. [DOI: 10.1002/prca.200800123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
134 Zhang F, Zhang L, Zhang B, Wei X, Yang Y, Qi RZ, Ying G, Zhang N, Niu R. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells. J Proteome Res 2009;8:5041-7. [PMID: 19764771 DOI: 10.1021/pr900461c] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
135 Herbert JMJ, Stekel DJ, Mura M, Sychev M, Bicknell R. Bioinformatic Methods for Finding Differentially Expressed Genes in cDNA Libraries, Applied to the Identification of Tumour Vascular Targets. In: Lu C, Browse J, Wallis JG, editors. cDNA Libraries. Totowa: Humana Press; 2011. pp. 99-119. [DOI: 10.1007/978-1-61779-065-2_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
136 de Graauw M, Cao L, Winkel L, van Miltenburg MHAM, le Dévédec SE, Klop M, Yan K, Pont C, Rogkoti V, Tijsma A, Chaudhuri A, Lalai R, Price L, Verbeek F, van de Water B. Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation. Oncogene 2014;33:2610-9. [DOI: 10.1038/onc.2013.219] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
137 Wang T, Yuan J, Zhang J, Tian R, Ji W, Zhou Y, Yang Y, Song W, Zhang F, Niu R. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells. Oncotarget 2015;6:30975-92. [PMID: 26307676 DOI: 10.18632/oncotarget.5199] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 9.2] [Reference Citation Analysis]
138 Zhao Z, Lu L, Li W. TAGLN2 promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of colorectal cancer cells by activating STAT3 signaling through ANXA2. Oncol Lett 2021;22:737. [PMID: 34466149 DOI: 10.3892/ol.2021.12998] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Massafra V, Milona A, Vos HR, Burgering BM, van Mil SW. Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation. PLoS One. 2017;12:e0171185. [PMID: 28178326 DOI: 10.1371/journal.pone.0171185] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
140 Ricciardelli C, Lokman NA, Ween MP, Oehler MK. WOMEN IN CANCER THEMATIC REVIEW: Ovarian cancer-peritoneal cell interactions promote extracellular matrix processing. Endocr Relat Cancer 2016;23:T155-68. [PMID: 27578826 DOI: 10.1530/ERC-16-0320] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
141 Wen J, Nikitakis NG, Chaisuparat R, Greenwell-Wild T, Gliozzi M, Jin W, Adli A, Moutsopoulos N, Wu T, Warburton G, Wahl SM. Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma. Am J Pathol 2011;178:2866-78. [PMID: 21641406 DOI: 10.1016/j.ajpath.2011.02.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
142 Wu B, Zhang F, Yu M, Zhao P, Ji W, Zhang H, Han J, Niu R. Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells. Cell Prolif. 2012;45:189-198. [PMID: 22452352 DOI: 10.1111/j.1365-2184.2012.00820.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
143 Bao J, Xu Y, Wang Q, Zhang J, Li Z, Li D, Li J. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2. Biomed Pharmacother. 2017;92:1030-1037. [PMID: 28609840 DOI: 10.1016/j.biopha.2017.06.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
144 Wang YX, Lv H, Li ZX, Li C, Wu XY. Effect of shRNA mediated down-regulation of Annexin A2 on biological behavior of human lung adencarcinoma cells A549. Pathol Oncol Res. 2012;18:183-190. [PMID: 21688086 DOI: 10.1007/s12253-011-9427-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
145 Wu W, Yu T, Wu Y, Tian W, Zhang J, Wang Y. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression. J Exp Clin Cancer Res. 2019;38:133. [PMID: 30898167 DOI: 10.1186/s13046-019-1132-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
146 Wu Y, V. Nguyen A, Wu X, Loh M, Vu M, Zou Y, Liu Q, Guo P, Wang Y, Montgomery LL, Orlofsky A, Rand JH, Lin EY. Antiphospholipid Antibodies Promote Tissue Factor–Dependent Angiogenic Switch and Tumor Progression. The American Journal of Pathology 2014;184:3359-75. [DOI: 10.1016/j.ajpath.2014.07.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
147 Hatoum D, Yagoub D, Ahadi A, Nassif NT, McGowan EM. Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer. PLoS One 2017;12:e0169925. [PMID: 28068434 DOI: 10.1371/journal.pone.0169925] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
148 Wang Y, Deng J, Guo G, Tong A, Peng X, Chen H, Xu J, Liu Y, You C, Zhou L. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma. J Neurooncol 2017;131:21-9. [DOI: 10.1007/s11060-016-2273-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
149 Wang J, Betancourt AM, Mobley JA, Lamartiniere CA. Proteomic discovery of genistein action in the rat mammary gland. J Proteome Res 2011;10:1621-31. [PMID: 21254785 DOI: 10.1021/pr100974w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]